BioSpace News Archive

Butterfly Network, Inc. announced that it will report first quarter 2023 financial results and provide a business update on May 11, 2023, before the market opens.

Entrinsic Bioscience is pleased to announce the upcoming poster session on the role of Enterade® Advanced Oncology Formula in reducing adverse gastrointestinal side effects for patients undergoing cancer treatment.

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), and MC2 Therapeutics today announced that results of a recently conducted survey to assess psoriasis patients’ topical treatment experience, expectations, and preferences have been published in the Journal of Drugs in Dermatology (JDD).

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a top 50 global specialty pharmaceutical company, today assumes primary commercial leadership for CRYSVITA® (burosumab-twza) injection in the United States and Canada from Ultragenyx Pharmaceutical, Inc., a transition planned for from the start of their decade-long collaboration.

Highlighting that cancer is no longer considered a sterile disease, Greg Sepich-Poore, Ph.D., Chief Analytic Officer and Co-founder of Micronoma, the first biotech company offering early cancer detection with a microbiome-driven, multi-omics liquid biopsy, shared the company’s impressive diagnostic capabilities in a presentation at the American Association for Cancer Research’s (AACR) annual meeting in Orlando, Florida.

Building on its focus to spark curiosity in the next generation of scientists and accelerate global access to science, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announces eight new and expanded Signature Partnerships for 2023-2025.

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, May 11, 2023, at 4:30 p.m. Eastern Time to review 2023 first quarter results.

In the news release, Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference, please note that the conference date is May 2nd, 2023.

NuVasive, Inc. (NASDAQ: NUVA) today announced that at the special meeting of shareholders held earlier today, its shareholders voted to approve the adoption of the Company’s merger agreement with Globus Medical (NYSE: GMED).

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (“BioHarvest” or the “company”) has announced that its VINIA partnership with House of Athlete trainer Yo Murphy has resulted in several of his high-profile players entering the NFL draft as members of “Team VINIA.”